Provided by Tiger Fintech (Singapore) Pte. Ltd.

ProPhase Labs

0.3926
-0.0331-7.78%
Post-market: 0.40990.0173+4.41%19:53 EDT
Volume:686.17K
Turnover:278.57K
Market Cap:11.87M
PE:-0.26
High:0.4258
Open:0.4129
Low:0.3900
Close:0.4257
Loading ...

Company Profile

Company Name:
ProPhase Labs
Exchange:
NASDAQ
Establishment Date:
1989
Employees:
113
Office Location:
711 Stewart Avenue,Suite 200,Garden City,New York,United States
Zip Code:
11530
Fax:
- -
Introduction:
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Directors

Name
Position
Ted Karkus
Chairman of the Board and Chief Executive Officer
Jason Barr
Director
Louis Gleckel
Director
Mark Burnett
Director
Mark Leventhal
Director

Shareholders

Name
Position
Ted Karkus
Chairman of the Board and Chief Executive Officer
Robert V. Cuddihy, Jr.
Executive Vice President, Chief Operating Officer and Chief Financial Officer